← Evidence map

ArticleClinical and experimental immunology2016

Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.

F Corvillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26660535